Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Adma Biologics Inc | 1,870,000 | 1,870,000 | 0 | $20.91M | $37.38M | 23.62% | +$16.47M |
| Evolus, Inc.(EOLS) | 1,657,611 | 1,369,821 | -287,790 | $17.99M | $22.19M | 14.02% | +$4.21M |
| Lakefront Biotherapeutics NVADR(LKFT) | 485,000 | 478,659 | -6,341 | $12.02M | $13.78M | 8.71% | +$1.76M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 55,000 | +55,000 | $0 | $6.13M | 3.87% | +$6.13M |
| Royalty Pharma plcCL A(RPRX) | 0 | 212,000 | +212,000 | $0 | $6.00M | 3.79% | +$6.00M |
| Xoma Corp | 250,129 | 195,096 | -55,033 | $5.93M | $5.17M | 3.26% | -$759.4K |
| Rigel Pharmaceuticals, Inc.(RIGL) | 305,000 | 309,100 | +4,100 | $2.51M | $5.00M | 3.16% | +$2.49M |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 700,000 | +700,000 | $0 | $4.86M | 3.07% | +$4.86M |
| Anika Therapeutics Inc | 165,397 | 189,308 | +23,911 | $4.19M | $4.68M | 2.95% | +$486.4K |
| Revance Therapeutics Inc | 2,800,000 | 820,000 | -1,980,000 | $7.20M | $4.26M | 2.69% | -$2.94M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 48,012 | 1,000,000 | +951,988 | $313.0K | $4.12M | 2.60% | +$3.81M |
| Verastem, Inc.(VSTM) | 0 | 1,310,287 | +1,310,287 | $0 | $3.92M | 2.48% | +$3.92M |
| Optinose Inc | 2,350,010 | 5,688,590 | +3,338,580 | $2.44M | $3.81M | 2.41% | +$1.37M |
| UroGen Pharma Ltd.(URGN) | 0 | 280,345 | +280,345 | $0 | $3.56M | 2.25% | +$3.56M |
| Scpharmaceuticals Inc | 421,703 | 778,874 | +357,171 | $1.83M | $3.55M | 2.24% | +$1.72M |
| Establishment Labs Holdings Inc.(ESTA) | 0 | 75,000 | +75,000 | $0 | $3.25M | 2.05% | +$3.25M |
| Acadia Pharmaceuticals Inc | 5,000 | 196,895 | +191,895 | $81.3K | $3.03M | 1.91% | +$2.95M |
| Day One Biopharmaceuticals I COM | 0 | 205,675 | +205,675 | $0 | $2.87M | 1.81% | +$2.87M |
| Aclaris Therapeutics, Inc.(ACRS) | 1,927,446 | 2,458,873 | +531,427 | $2.12M | $2.83M | 1.79% | +$707.5K |
| TELA Bio, Inc.(TELA) | 625,645 | 1,110,000 | +484,355 | $2.94M | $2.81M | 1.77% | -$132.2K |
| Indivior Plc | 0 | 270,000 | +270,000 | $0 | $2.63M | 1.66% | +$2.63M |
| Exagen Inc.(XGN) | 358,697 | 534,398 | +175,701 | $652.8K | $1.65M | 1.04% | +$998.5K |
| Milestone Pharmaceuticals Inc.(MIST) | 1,239,199 | 999,790 | -239,409 | $1.64M | $1.52M | 0.96% | -$116.1K |
| Surrozen, Inc.(SRZN) | 1,584 | 110,000 | +108,416 | $17.3K | $1.32M | 0.83% | +$1.30M |
| Aytu Biopharma Inc | 472,469 | 500,958 | +28,489 | $1.38M | $1.18M | 0.74% | -$202.4K |
| Kezar Life Sciences Inc | 1,050,452 | 1,491,305 | +440,853 | $630.3K | $1.15M | 0.73% | +$522.8K |
| Adicet Bio Inc | 609,446 | 609,446 | 0 | $737.4K | $877.6K | 0.55% | +$140.2K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 88,457 | +88,457 | $0 | $822.6K | 0.52% | +$822.6K |
| Paragon 28 Inc | 0 | 114,724 | +114,724 | $0 | $766.4K | 0.48% | +$766.4K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 0 | 202,400 | +202,400 | $0 | $740.8K | 0.47% | +$740.8K |
| PolyPid Ltd.(PYPD) | 0 | 138,504 | +138,504 | $0 | $476.5K | 0.30% | +$476.5K |
| 2seventy Bio Inc | 100,000 | 100,000 | 0 | $385.0K | $472.0K | 0.30% | +$87.0K |
| Myomo, Inc.(MYO) | 0 | 100,000 | +100,000 | $0 | $401.0K | 0.25% | +$401.0K |
| Aprea Therapeutics, Inc.(APRE) | 137,174 | 137,174 | 0 | $558.3K | $377.2K | 0.24% | -$181.1K |
| Iteos Therapeutics Inc | 0 | 30,000 | +30,000 | $0 | $306.3K | 0.19% | +$306.3K |
| Tenax Therapeutics, Inc.(TENX) | 0 | 50,000 | +50,000 | $0 | $173.0K | 0.11% | +$173.0K |
| Viracta Therapeutics Inc | 0 | 500,000 | +500,000 | $0 | $115.7K | 0.07% | +$115.7K |
| Alimera Sciences Inc Cvr | 0 | 2,408,469 | +2,408,469 | $0 | $96.3K | 0.06% | +$96.3K |
| Alimera Sciences Inc | 3,511,816 | 0 | -3,511,816 | $19.53M | $0 | — | -$19.53M |
| Aurinia Pharmaceuticals Inc.(AUPH) | 300,000 | 0 | -300,000 | $1.71M | $0 | — | -$1.71M |
| Eton Pharmaceuticals, Inc.(ETON) | 110,000 | 0 | -110,000 | $361.9K | $0 | — | -$361.9K |
| Kiora Pharmaceuticals Inc | 200,000 | 0 | -200,000 | $840.0K | $0 | — | -$840.0K |